...
机译:使用Busulfan / Melphalan,自体造血细胞移植,抗GD2抗体,粒细胞 - 巨噬细胞刺激因子,白细胞介素-2和Haploidentical自然杀伤细胞进行新诊断的小型神经母细胞瘤的新诊断的儿科患者
Department of Bone Marrow Transplantation and Cellular Therapy St. Jude Children's Research;
Department of Bone Marrow Transplantation and Cellular Therapy St. Jude Children's Research;
Department of Oncology St. Jude Children's Research Hospital;
Department of Bone Marrow Transplantation and Cellular Therapy St. Jude Children's Research;
Department of Bone Marrow Transplantation and Cellular Therapy St. Jude Children's Research;
Department of Biostatistics St. Jude Children's Research Hospital;
Department of Bone Marrow Transplantation and Cellular Therapy St. Jude Children's Research;
Department of Bone Marrow Transplantation and Cellular Therapy St. Jude Children's Research;
Department of Oncology St. Jude Children's Research Hospital;
GD2 monoclonal antibody; Neuroblastoma; Autologous transplantation; Immunotherapy; Natural killer cells;
机译:使用Busulfan / Melphalan,自体造血细胞移植,抗GD2抗体,粒细胞 - 巨噬细胞刺激因子,白细胞介素-2和Haploidentical自然杀伤细胞进行新诊断的小型神经母细胞瘤的新诊断的儿科患者
机译:自体骨髓移植或干细胞抢救后神经母细胞瘤儿童ch14.18与粒细胞巨噬细胞集落刺激因子和白细胞介素2的I期研究:儿童肿瘤小组的报告。
机译:自体骨髓移植或干细胞抢救后神经母细胞瘤儿童ch14.18与粒细胞巨噬细胞集落刺激因子和白细胞介素2的I期研究:儿童肿瘤小组的报告。
机译:在65例Al淀粉样蛋白患者中,具有自体蛋白化疗的高剂量蛋白化疗:器官进展可以延迟达到完全缓解的患者
机译:粒细胞巨噬细胞集落刺激因子/白细胞介素2融合cDNA的表征以及骨髓基质细胞在癌症免疫治疗中的应用。
机译:使用白消安/美法仑自体造血细胞移植抗GD2抗体GM-CSFIL-2和单倍性NK细胞对新诊断的小儿高危神经母细胞瘤患者进行巩固治疗
机译:新诊断阶段IV和复发外自然杀伤/ T细胞淋巴瘤患者的自体干细胞移植综合的多中心研究